MB-26 TARGETING MEDULLOBLASTOMA WITH A NEW SMALL-MOLECULE DRUG THAT INHIBITS MYC MEDIATED TRANSLATION

類似資料

• MB-22 CHECKPOINT KINASE 1 EXPRESSION IS AN ADVERSE PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN MYC-DRIVEN MEDULLOBLASTOMA
  著者:: Prince, Eric, 等
  出版事項: (2015)
• MB-71 THE ROLE OF WEE1 IN Myc-DRIVEN MEDULLOBLASTOMA
  著者:: Moreira, Daniel, 等
  出版事項: (2016)
• AT-04 TARGETING Myc DRIVEN TRANSCRIPTIONAL OUTPUT IN ATYPICAL TERATOID RHABDOID TUMOR
  著者:: Alimova, Irina, 等
  出版事項: (2015)
• MEDU-33. PLK1 INHIBITION IN COMBINATION WITH STANDARD THERAPIES FOR MYC-DRIVEN MEDULLOBLASTOMA
  著者:: Balakrishnan, Ilango, 等
  出版事項: (2017)
• MB-20 WDR5 ORCHESTRATES CANCER CELL SELF RENEWAL IN Myc DRIVEN MEDULLOBLASTOMA
  著者:: Ghosh, Swati, 等
  出版事項: (2016)